
Wednesday, December 18, 2019 12:53:24 PM
Recent MIRM News
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/11/2025 12:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:35:29 PM
- Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer • Business Wire • 05/19/2025 12:30:00 PM
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 05/14/2025 08:05:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/09/2025 10:00:00 PM
- Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL • Business Wire • 05/09/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 08:08:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 08:02:22 PM
- Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update • Business Wire • 05/07/2025 08:01:00 PM
- Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 • Business Wire • 04/30/2025 12:30:00 PM
- Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses • Business Wire • 04/28/2025 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/14/2025 08:16:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2025 08:07:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/14/2025 08:06:12 PM
- Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation • Business Wire • 04/14/2025 12:30:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/10/2025 11:00:00 PM
- LIVMARLI Now Approved in Japan for ALGS and PFIC • Business Wire • 03/27/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 09:40:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 01:30:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2025 08:12:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2025 08:21:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2025 09:17:47 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2025 09:09:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 09:06:04 PM
- Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update • Business Wire • 02/26/2025 09:01:00 PM
FEATURED Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • Jun 17, 2025 8:00 AM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM